| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Galectin Therapeutics Inc (GALT) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. GALT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.33M | $23.04M | - | |
| 10% | 5.61M | $12.52M | - | |
| CFO | 100.0K | $223.0K | - | |
| CEO | 100.0K | $223.0K | - | |
| Other | 100.0K | $223.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2017 | Freeman Kevin D | Director | Buy | 8,400 | $1.63 | $13,662.12 | +30.4% | |
| May 23, 2017 | Zucconi Theodore Daniel | Director | Buy | 1,000 | $2.27 | $2,270.00 | +1,205% | |
| Apr 20, 2016 | Czirr James C | Director | Sell | 44,312 | $1.67 | $74,138.30 | -0.7% | |
| Apr 20, 2016 | 10x Fund, L.P.85 | 10% Owner | Sell | 44,312 | $1.67 | $74,138.30 | -0.7% | |
| Jan 5, 2016 | Greenberg Arthur | Director | Buy | 1,666 | $1.72 | $2,865.52 | +1.5% | |
| Nov 30, 2015 | Amelio Gilbert F | Director | Sell | 100 | $2.10 | $210.00 | - | |
| Aug 12, 2015 | Traber Peter G59 | President &CEO | Buy | 2,000 | $2.00 | $4,000.00 | +1.9% | |
| Jun 1, 2015 | Freeman Kevin D56 | Director | Buy | 2,083 | $2.70 | $5,624.10 | New | |
| Jun 1, 2015 | Traber Peter G59 | President &CEO | Buy | 4,000 | $2.53 | $10,120.00 | +3.9% |